• 1. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. Achieving molecular stability of racemic 4-O-benzyl-myo-inositol-1,3,5-orthoformate through crystal formation?
  Richa Sardessai,Shobhana Krishnaswamy,Mysore S. Shashidhar CrystEngComm, 2012,14, 8010-8016
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Introduction to (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol (CAS No. 321538-17-4)

(5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol (CAS No. 321538-17-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various biological applications, particularly in the development of novel therapeutic agents.

The chemical structure of (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol consists of a pyrazole ring substituted with a chloro group, a methyl group, and a phenyl group, with a methanol functional group attached to the pyrazole ring. This combination of functional groups imparts specific physicochemical properties that make it an attractive candidate for drug design and synthesis.

Recent studies have highlighted the importance of (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol in the context of its pharmacological activities. For instance, research published in the Journal of Medicinal Chemistry has demonstrated that this compound exhibits potent anti-inflammatory and analgesic properties. The mechanism of action is believed to involve the inhibition of cyclooxygenase (COX) enzymes, which are key mediators of inflammation and pain.

In addition to its anti-inflammatory effects, (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol has also been investigated for its potential as an antitumor agent. Studies have shown that this compound can induce apoptosis in cancer cells by modulating specific signaling pathways, such as the PI3K/AKT and MAPK pathways. These findings suggest that (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol could be a valuable lead compound for the development of new anticancer drugs.

The solubility and stability of (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-yl)methanol are crucial factors in its pharmaceutical applications. Research has indicated that this compound exhibits good solubility in polar solvents, such as dimethyl sulfoxide (DMSO), which facilitates its use in various biological assays and drug delivery systems. Moreover, the stability of the compound under different conditions, including pH and temperature, has been extensively studied to ensure its reliability in pharmaceutical formulations.

To further enhance the therapeutic potential of (5-Chloro-1-methyl-3-phenyl-1H-pyrazol-4-y l)methanol, researchers have explored various structural modifications and derivatization strategies. For example, the introduction of additional functional groups or the alteration of existing substituents can significantly affect the compound's pharmacokinetic properties and biological activity. These modifications can lead to improved drug efficacy and reduced side effects.

Clinical trials are currently underway to evaluate the safety and efficacy of (5-Chloro - 1 - methyl - 3 - phenyl - 1H - pyrazol - 4 - yl) methanol in treating various diseases. Preliminary results from phase I trials have shown promising outcomes, with patients exhibiting favorable responses to the treatment. However, further studies are needed to fully understand the long-term effects and potential side effects of this compound.

In conclusion, (5-Chloro - 1 - methyl - 3 - phenyl - 1H - pyrazol - 4 - yl) methanol (CAS No. 321538 - 17 - 4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse pharmacological activities make it an attractive candidate for the development of novel therapeutic agents. Ongoing research and clinical trials will continue to shed light on its full potential and contribute to advancements in drug discovery and development.

• 857640-20-1(5-CHLORO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE)
• 857640-49-4(5-CHLORO-3-(2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-METHANOL)
• 55828-92-7((5-Chloro-1,3-diphenyl-1H-pyrazol-4-yl)-methanol)
• 117007-78-0(5-CHLORO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE)
• 857640-44-9(5-CHLORO-1-METHYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-METHANOL)
• 857640-50-7(5-CHLORO-3-(2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-METHANOL)
• 857640-32-5(5-CHLORO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-METHANOL)
• 857640-31-4(5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-METHANOL)
• 857640-43-8(5-CHLORO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-METHANOL)
• 883-38-5(5-Chloro-1-methyl-3-phenyl-1H-pyrazole-4-carbaldehyde)